MaxsMaking Inc. Notified of Anticipated Delisting from The Nasdaq Stock Market

Nasdaq (NDAQ) notified MaxsMaking (MAMK) that its securities are scheduled for delisting from the Nasdaq Stock Market on July 28, 2026, unless the company appeals to a Listing Qualifications Hearings Panel.

Rhea-AI Summary

Nasdaq (NDAQ) notified MaxsMaking (MAMK) that its securities are scheduled for delisting from the Nasdaq Stock Market on July 28, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. Trading in MaxsMaking’s Nasdaq-listed securities remains halted and could later move to over-the-counter markets.

Positive

• Potential over-the-counter trading eligibility after Nasdaq delisting
• Company retains right to appeal delisting to hearings panel

Negative

• Nasdaq plans to delist MaxsMaking securities on July 28, 2026
• MaxsMaking securities remain halted and unavailable for trading
• Nasdaq is exercising authority under IM-5101-4 to delist
• Prior SEC trading suspension and Nasdaq halt since December 2, 2025

News Explained

MaxsMaking’s ordinary shares have been halted since December 2, 2025, and its securities will remain unavailable to trade until any delisting appeal is resolved, so July 28, 2026 is not a scheduled trading resumption.

Argus Jul 20 session

+0.25% close to close Open Argus

Details

News Market Reaction – NDAQ

In the Jul 20 session, NDAQ gained 0.25%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical event news_id 1080498 provides a direct comparison for this delisting notice. The platfor...

Analysis

Historical event news_id 1080498 provides a direct comparison for this delisting notice. The platform also recorded Net Buying among recent insiders; low short positioning adds context, while the appeal outcome remains the stated uncertainty.

Key Figures

Anticipated delisting date: July 28, 2026 Trading halt date: December 2, 2025

Anticipated delisting date

July 28, 2026

Unless the company appeals

Trading halt date

December 2, 2025

Following an SEC trading suspension

Historical Context

5 past events · Latest: Jul 10

5 events

1. Jul 10

   Delisting announcement

   24h Move

   +0.6%

   Nasdaq announced delistings for issuers whose trading remained suspended.

2. Jul 08

   Trading volume update

   24h Move

   +3.7%

   Nasdaq reported June volumes and second-quarter 2026 market statistics.

3. Jul 07

   Delisting notice

   24h Move

   -2.4%

   Pitanium received notice of anticipated delisting unless it appealed.

4. Jul 07

   Delisting notice

   24h Move

   -2.4%

   Platinum Analytics received notice of anticipated delisting and continued trading halt.

5. Jul 06

   Opening bell event

   24h Move

   -0.2%

   Nasdaq marked America 250 and the first trading day for Trump Accounts.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

listing qualifications hearings panel, over-the-counter market, im-5101-4

3 terms

listing qualifications hearings panel regulatory

"unless the company appeals to a Listing Qualifications Hearings Panel"

A listing qualifications hearings panel is a review board at a stock exchange that evaluates whether a company still meets the exchange’s rules for being listed, such as minimum share price, financial reporting, or governance standards. Think of it as a referee deciding if a team can stay in the league; its decisions can affect a stock’s ability to trade on the exchange, liquidity, investor confidence, and ultimately share value.

over-the-counter market financial

"the securities may be eligible for trading in the over-the-counter market"

A market where securities are bought and sold directly between dealers and brokers instead of on a centralized stock exchange. Think of it like a neighborhood bazaar compared with a big supermarket: prices and rules can vary, oversight is lighter, and some instruments are harder to trade or riskier. Investors care because OTC listings can offer access to small or specialized investments but often come with higher price volatility, lower liquidity, and greater information risk.

im-5101-4 regulatory

"use its authority under IM-5101-4 to delist the Company’s securities"

An investigational product code name for a drug or medical therapy under development and testing. Think of it as a prototype being evaluated in clinical studies to prove it works and is safe; positive or negative trial results, safety findings, or regulatory decisions about it can materially affect the developer’s future revenue prospects and share price. Investors watch such codes because they signal potential new products, timelines to market, and the level of scientific and regulatory risk involved.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified MaxsMaking Inc. (Nasdaq: MAMK) that its securities will be delisted from the Nasdaq Stock Market LLC on July 28, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market. 

Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104180.pdf) Nasdaq halted trading in the Company’s ordinary shares on December 2, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.

For news and additional information about the company, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.  

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why is MaxsMaking (MAMK) being delisted from the Nasdaq Stock Market?

MaxsMaking is being delisted because Nasdaq determined it is appropriate to use its authority under IM-5101-4. According to Nasdaq, this follows an SEC trading suspension and a Nasdaq trading halt in the company’s ordinary shares that began on December 2, 2025.

When will MaxsMaking (MAMK) be delisted from Nasdaq and can it appeal?

Nasdaq plans to delist MaxsMaking securities on July 28, 2026, unless the company appeals. According to Nasdaq, MaxsMaking may request a hearing before a Listing Qualifications Hearings Panel, during which the securities remain halted until any appeal is resolved.

Can MaxsMaking (MAMK) shares trade after being delisted from Nasdaq?

MaxsMaking shares may be eligible for trading in the over-the-counter market after Nasdaq delisting. According to Nasdaq, the current Nasdaq-listed securities remain halted and unavailable to trade until any appeal process is completed and the delisting decision is finalized.

Why are MaxsMaking (MAMK) shares currently halted on Nasdaq?

MaxsMaking shares are halted following an earlier SEC temporary trading suspension and Nasdaq’s subsequent halt on December 2, 2025. According to Nasdaq, the company’s securities will remain halted and unavailable to trade on Nasdaq until any delisting appeal is fully resolved.

Where can investors find official information about the MaxsMaking (MAMK) delisting from Nasdaq?

Investors should review MaxsMaking’s public filings or contact the company directly for details. According to Nasdaq, its delisting rules are available in the Nasdaq Rule 5800 Series on the Nasdaq Listing Center and general market information appears on Nasdaq’s main website.

What Nasdaq rules govern the delisting of MaxsMaking (MAMK) securities?

The delisting is guided by Nasdaq’s authority under IM-5101-4 and broader rules in the Nasdaq Rule 5800 Series. According to Nasdaq, these rules set the procedures and standards for suspending, halting, and delisting securities from the Nasdaq Stock Market.